These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20045294)

  • 21. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis.
    Cirioni O; Wu G; Li L; Orlando F; Silvestri C; Ghiselli R; Shen Z; Gabrielli E; Brescini L; Lezoche G; Provinciali M; Guerrieri M; Giacometti A
    Peptides; 2011 Apr; 32(4):697-701. PubMed ID: 21262298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
    Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
    Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.
    Pini A; Falciani C; Mantengoli E; Bindi S; Brunetti J; Iozzi S; Rossolini GM; Bracci L
    FASEB J; 2010 Apr; 24(4):1015-22. PubMed ID: 19917670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
    Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
    Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.
    Yibin G; Jiang Z; Hong Z; Gengfa L; Liangxi W; Guo W; Yongling L
    Biochem Pharmacol; 2005 Jul; 70(2):209-19. PubMed ID: 15935330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli.
    Hou Z; Lu J; Fang C; Zhou Y; Bai H; Zhang X; Xue X; Chen Y; Luo X
    J Infect Dis; 2011 Jan; 203(2):273-82. PubMed ID: 21288828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibacterial activity of recombinant thanatin expressed by E.coli ER2566].
    Wang PZ; Gu JB; Luo J; Peng HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1050-4. PubMed ID: 20501392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.
    Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O
    J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subacute toxicity of antimicrobial peptide S-thanatin in ICR mice.
    Wu G; Deng X; Wu P; Shen Z; Xu H
    Peptides; 2012 Jul; 36(1):109-13. PubMed ID: 22537943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis.
    Cirioni O; Wu G; Li L; Orlando F; Silvestri C; Ghiselli R; Shen Z; Scalise A; Gabrielli E; Scuppa D; Romiti C; Provinciali M; Guerrieri M; Giacometti A
    Peptides; 2010 Jul; 31(7):1231-6. PubMed ID: 20381561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
    Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
    Rosenfeld Y; Lev N; Shai Y
    Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
    Rosenfeld Y; Sahl HG; Shai Y
    Biochemistry; 2008 Jun; 47(24):6468-78. PubMed ID: 18498177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332.
    Wu G; Ding J; Li H; Li L; Zhao R; Shen Z; Fan X; Xi T
    Curr Microbiol; 2008 Dec; 57(6):552-7. PubMed ID: 18810542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
    Ghiselli R; Silvestri C; Cirioni O; Kamysz W; Orlando F; Calcinari A; Kamysz E; Casteletti S; Rimini M; Tocchini M; Giacometti A; Guerrieri M
    J Surg Res; 2011 Dec; 171(2):726-33. PubMed ID: 20605608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and genotypic antimicrobial resistance patterns of Escherichia coli isolated from dairy cows with mastitis.
    Srinivasan V; Gillespie BE; Lewis MJ; Nguyen LT; Headrick SI; Schukken YH; Oliver SP
    Vet Microbiol; 2007 Oct; 124(3-4):319-28. PubMed ID: 17544234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of antibacterial peptide PR-39 in a neonatal murine model of endotoxic shock.
    Delfino D; Cusumano VV; Tomasello F; Cusumano V
    New Microbiol; 2004 Oct; 27(4):369-74. PubMed ID: 15646051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.